FIQIX
Price
$31.58
Change
+$0.70 (+2.27%)
Updated
Apr 11 closing price
Net Assets
4.73B
TTISX
Price
$10.60
Change
+$0.26 (+2.51%)
Updated
Apr 11 closing price
Net Assets
1.11B
Ad is loading...

FIQIX vs TTISX

Header iconFIQIX vs TTISX Comparison
Open Charts FIQIX vs TTISXBanner chart's image
Fidelity Advisor Intl Small Cap Z
Price$31.58
Change+$0.70 (+2.27%)
VolumeN/A
Net Assets4.73B
Nuveen Quant Intl Sm Cap Eq Retirement
Price$10.60
Change+$0.26 (+2.51%)
VolumeN/A
Net Assets1.11B
FIQIX vs TTISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIQIX vs. TTISX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIQIX is a Hold and TTISX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FIQIX has more cash in the bank: 4.73B vs. TTISX (1.11B). TTISX pays higher dividends than FIQIX: TTISX (2.90) vs FIQIX (2.60). FIQIX was incepted earlier than TTISX: FIQIX (7 years) vs TTISX (8 years). TTISX (0.99) is less costly to investors than FIQIX (0.92). TTISX is a more actively managed with annual turnover of: 114.00 vs. FIQIX (17.00). FIQIX (0) and TTISX (0) have matching initial minimum investment requirements. FIQIX annual gain was more profitable for investors over the last year : -1.53 vs. TTISX (-1.69). FIQIX return over 5 years is better than : 59.22 vs. TTISX (53.16).
FIQIXTTISXFIQIX / TTISX
Total Expense Ratio0.920.9993%
Annual Report Gross Expense Ratio0.920.9993%
Fund Existence7 years8 years-
Gain YTD0.390-1.336-29%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets4.73B1.11B425%
Annual Yield % from dividends2.602.9090%
Returns for 1 year-1.53-1.6991%
Returns for 3 years11.534.34266%
Returns for 5 years59.2253.16111%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRWUX21.49N/A
N/A
MFS Blended Research Growth Eq R4
MSEEX21.66N/A
N/A
Morgan Stanley Europe Opportunity C
TAINX20.76N/A
N/A
Transamerica International Equity R6
OAYGX31.08N/A
N/A
Oakmark Global Advisor
VXTRF0.02N/A
-1.36%
VOXTUR ANALYTICS CORP.